Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for sleep disturbance in healthy adults
ACTRN12621000632897Phase 3Completed
- Sponsor
- Southern Cross University
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sleep disorder comparing Cannabidiol with Placebo (2 arms). Primary endpoint: PROMIS Sleep Disturbance score. Started Sep 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ACTRN12621000632897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000632897.